Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

1. Renal denervation in the antihypertensive arsenal – knowns and known unknowns

   Franz H. Messerli, Chirag Bavishi, Jana Brguljan +18

   МақолаBlood Pressure and Hypertension StudiesJournal of Hypertension20223 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.134879

2. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

   И Е Чазова, Yu. V. Zhernakova, N. V. Blinova +19

   МақолаCardiac Health and Mental HealthEurasian heart journal20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.000532

3. Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)

   И Е Чазова, Yu. V. Zhernakova, N. V. Blinova +20

   МақолаCardiac Health and Mental HealthEurasian heart journal20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.009850